Worth reading the coverage from STAT News: To view or add a comment, sign in Tirzepatide: Redefining Outcomes in Diabetes & Obesity Care Clinical trials show tirzepatide, a dual GIP/GLP-1 receptor agonist, is delivering results beyond expectations: Up to 20.9% mean weight loss at 72 weeks (SURMOUNT-1, NEJM) 94% risk reduction in progression from prediabetes to type 2 diabetes over 3 years Superior HbA1c reduction and weight control vs leading GLP-1 therapies (SURPASS program) With manageable side effects and durable outcomes, tirzepatide is reshaping how we approach metabolic disease
Xu Y, Liu L, Xin W, Zhao X, Chen L, Zhen J, et al
At Kelowna Hills, we focus on delivering personalized, physician-guided wellness care that fits seamlessly into your lifestyle
Differential effects of oral and intravenous l-carnitine on serum lipids: is the microbiota the answer?
"Role of topical peptides in preventing or treating aged skin." Skin Pharmacology and Physiology
Since Lexapro is a prescription medication, youll need to consult with a doctor or nurse practitioner before getting it